Foresight

Press release - Media Advisory: Hearing of Commission Executive Vice-President Šefčovič on 3 October

Retrieved on: 
Monday, October 2, 2023
HD, Rural development, Accreditation, European Parliament, Food safety, Conference of Presidents (Greece), Hearing, European, Commission, Conference of Presidents of the European Parliament, Transport, Member of the European Parliament, European Green Deal, Parliament, Committee, European Parliament Committee on Industry, Research and Energy, European Parliament Committee on the Environment, Public Health and Food Safety, Public health, MEP, Agriculture, Michigan Department of Agriculture and Rural Development, Environment, Tourism, Foresight, Research, Conference, Management, Television, Hospital, Industry

Media Advisory: Hearing of Commission Executive Vice-President Šefčovič on 3 October

Key Points: 
  • Media Advisory: Hearing of Commission Executive Vice-President Šefčovič on 3 October
    This advisory provides practical information on the hearing of Maroš Šefčovič (Slovakia) taking place on 3 October from 8.30 to 11.30.
  • The committees on Industry, Research and Energy, on Transport and Tourism and on Agriculture and Rural Development will participate in his hearing.
  • The hearing will take place from 8.30 to 11.30 in the European Parliament in Strasbourg in meeting room WEISS S1.4.
  • A press point by the committee chair Mr. Pascal Canfin (Renew, FR) is scheduled to take place after the hearing, next to the meeting room (tbc).

Foresight Research Releases 2023 New Vehicle Accessory Sales/Marketing/Product Report

Retrieved on: 
Thursday, September 21, 2023
Foresight, Research, Marketing

Then Foresight Research analyzed the brands with the highest accessory installation rates to find out what they do that can be adopted by your brand.

Key Points: 
  • Then Foresight Research analyzed the brands with the highest accessory installation rates to find out what they do that can be adopted by your brand.
  • Key areas that are explored in this report:
    In the product section, Foresight Research measured five accessory installation categories – installation rates by region and segment.
  • Foresight Research is a proven leader in automotive marketing research and consumer insights since 1998.
  • Our Automotive Accessory Group publishes annual syndicated reports on the US new vehicle accessory market and on the sales and marketing of accessories.

Foresight Partners with One of the World's Largest Electric Vehicle Manufacturers

Retrieved on: 
Thursday, September 21, 2023
EV, Perception, EVS, Map, TASE, Foresight, OEM, POC, Safety, Management, Chinese

Ness Ziona, Israel, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, announced today the signing of a multi-phase cooperation agreement with a leading global electric vehicle (EV) Chinese original equipment manufacturer (OEM), specializing in EVs, rechargeable batteries and related products.

Key Points: 
  • Upon successful completion of the POC project, the parties intend to negotiate a definitive commercial agreement for the joint development, integration and commercialization of Foresight’s technology into the OEM’s automotive vision systems.
  • Furthermore, the OEM will introduce Foresight’s technology to its subsidiaries as well as customers and partners, presenting Foresight as a business partner and facilitating relationships between Foresight and the OEM’s partners.
  • A senior executive at the Chinese OEM stated, “we are constantly looking for cutting-edge and competitive technologies to retain our leadership.
  • We look forward to teaming up with Foresight to enhance our 3D perception vision systems.

Foresee Pharmaceuticals Presents Data From its Aderamastat Program at The European Respiratory Society (ERS) International Congress 2023

Retrieved on: 
Tuesday, September 12, 2023
European Respiratory Society, Human, Asthma, International, HDM, IOS, Lung, ERS, Foresight, Patient, SNP, LAR, AX, Second International Congress on Education of the Deaf, FEV1, Pharmaceutical industry, R5

TAIPEI, Sept. 12, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today that the company presented the positive primary outcomes of its aderamastat (FP-025) Phase 2 proof-of-concept allergic asthma study at the European Respiratory Society (ERS) International Congress 2023 taking place in Milan, Italy from September 9-13, 2023.

Key Points: 
  • Late-breaking oral presentation on the positive primary outcomes of aderamastat, a first-in-class, oral MMP-12 inhibitor in a Phase 2 Phase 2 proof-of-concept allergic asthma study, supporting potential novel anti-inflammatory mechanism for respiratory diseases.
  • TAIPEI, Sept. 12, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today that the company presented the positive primary outcomes of its aderamastat (FP-025) Phase 2 proof-of-concept allergic asthma study at the European Respiratory Society (ERS) International Congress 2023 taking place in Milan, Italy from September 9-13, 2023.
  • It was a real pleasure to share this promising data with such a remarkable group of scientists and clinicians in the field of respiratory diseases.
  • "This Phase 2 study demonstrates that the inhibition of MMP-12 in humans is in line with the MMP-12 single-nucleotide polymorphism (SNP) data, human expression data, and animal pharmacology models.

Foresee Pharmaceuticals Presents Data From its Aderamastat Program at The European Respiratory Society (ERS) International Congress 2023

Retrieved on: 
Tuesday, September 12, 2023
European Respiratory Society, Human, Asthma, International, HDM, IOS, Lung, ERS, Foresight, Patient, SNP, LAR, AX, Second International Congress on Education of the Deaf, FEV1, Pharmaceutical industry, R5

TAIPEI, Sept. 11, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today that the company presented the positive primary outcomes of its aderamastat (FP-025) Phase 2 proof-of-concept allergic asthma study at the European Respiratory Society (ERS) International Congress 2023 taking place in Milan, Italy from September 9-13, 2023.

Key Points: 
  • Late-breaking oral presentation on the positive primary outcomes of aderamastat, a first-in-class, oral MMP-12 inhibitor in a Phase 2 Phase 2 proof-of-concept allergic asthma study, supporting potential novel anti-inflammatory mechanism for respiratory diseases.
  • TAIPEI, Sept. 11, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today that the company presented the positive primary outcomes of its aderamastat (FP-025) Phase 2 proof-of-concept allergic asthma study at the European Respiratory Society (ERS) International Congress 2023 taking place in Milan, Italy from September 9-13, 2023.
  • It was a real pleasure to share this promising data with such a remarkable group of scientists and clinicians in the field of respiratory diseases.
  • "This Phase 2 study demonstrates that the inhibition of MMP-12 in humans is in line with the MMP-12 single-nucleotide polymorphism (SNP) data, human expression data, and animal pharmacology models.

Panaya Revolutionizes Salesforce Org Management with ForeSight ExplAIn: Empowering Salesforce Professionals with AI-Powered Clarity

Retrieved on: 
Tuesday, September 5, 2023
Cloud, Intelligence, Component, LLM, Software as a service, Business, ERP, Automation, Privacy, Organization, Documentation, Foresight, Risk, Head, CRM, AI, Medical device, Salesforce

Hackensack, N.J., Sept. 5, 2023 /PRNewswire/ -- Panaya, the leader in SaaS-based Change Intelligence and Smart Testing for CRM, ERP & Enterprise Cloud Applications, unveils its latest innovation, ForeSight ExplAIn. In response to the increasing complexity of Salesforce customizations and the need for efficient error resolution, ForeSight ExplAIn harnesses the power of AI to provide clear, human-readable explanations for day-to-day customizations and error messages, revolutionizing the way organizations manage their Salesforce environments.

Key Points: 
  • Complex Salesforce configurations can lead to inefficiencies in troubleshooting and delayed issue resolution, affecting operational efficiency.
  • The addition of ForeSight ExplAIn to Panaya's portfolio further solidifies its commitment to simplifying and optimizing the management of Salesforce environments.
  • ForeSight ExplAIn marks a significant leap forward in Salesforce Org management," says Avi Rosenfeld, General Manager, Panaya ForeSight Line of Business.
  • ForeSight ExplAIn provides our customers with the means to easily navigate the landscape of Salesforce customizations and error resolution, ensuring optimal performance and success.

Foresight Signs Agreement with Global Vehicle Manufacturer

Retrieved on: 
Monday, August 14, 2023
Perception, ADAS, Foresight, POC, Safety, Classification, TASE, Satellite navigation device

Ness Ziona, Israel, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, announced today the signing of an agreement for two proof of concept (POC) projects with a leading global vehicle manufacturer.

Key Points: 
  • Ness Ziona, Israel, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, announced today the signing of an agreement for two proof of concept (POC) projects with a leading global vehicle manufacturer.
  • The vehicle manufacturer currently uses stereo cameras in its advanced driver assistance systems (ADAS), enabling 3D depth perception and distance analysis.
  • The vehicle manufacturer has chosen to evaluate Foresight’s stereo vision solutions to improve safety measures even further.
  • "We believe that our collaboration with another leading global vehicle manufacturer validates the importance of Foresight’s technology in the automotive world and could lead to additional opportunities in the automotive sector.

Foresight Welcomes New Underwriting Hire

Retrieved on: 
Thursday, August 17, 2023
Cori, Learning, Calcomp, Foresight, SAN, Insurance, Mount Everest

SAN FRANCISCO, Aug. 17, 2023 /PRNewswire/ -- Foresight Commercial Insurance , the workers' compensation provider that reduces claims frequency with proprietary safety technology, today announced a new underwriter hire with deep industry knowledge.

Key Points: 
  • SAN FRANCISCO, Aug. 17, 2023 /PRNewswire/ -- Foresight Commercial Insurance , the workers' compensation provider that reduces claims frequency with proprietary safety technology, today announced a new underwriter hire with deep industry knowledge.
  • Cori Walker began her career in IT before finding her passion in underwriting.
  • I look forward to working with her to build on the great momentum Foresight has in the region," said David Fontain, CEO and co-founder of Foresight.
  • Cori joins three other recent underwriting hires at Foresight.

Foresight Diagnostics Strengthens Leadership Team with Addition of Chief Business Officer John Truesdell

Retrieved on: 
Thursday, August 17, 2023
University of Colorado Boulder, United States Navy, University, Boston Scientific, NGS, Harvard–MIT Program in Health Sciences and Technology, Cancer, MIT Sloan School of Management, MBA, MS, MRD, Developmental Biology (journal), Patient, Standard of care, Outline of health sciences, Foresight, Foundation Medicine, Pharmaceutical industry, Management, Teleflex, Biochemistry

AURORA, Colo., Aug. 17, 2023 /PRNewswire/ -- Foresight Diagnostics, a leading provider of ultrasensitive cancer detection tests, today announced the appointment of John Truesdell as Chief Business Officer.

Key Points: 
  • AURORA, Colo., Aug. 17, 2023 /PRNewswire/ -- Foresight Diagnostics, a leading provider of ultrasensitive cancer detection tests, today announced the appointment of John Truesdell as Chief Business Officer.
  • John comes to Foresight most recently from SeQure Dx, where he served as Chief Business Officer.
  • "John's breadth of commercial leadership experience within this space make him an ideal addition to the Foresight Team," said Jake Chabon, CEO of Foresight Diagnostics.
  • "I am delighted to join Foresight Diagnostics as Chief Business Officer," said John Truesdell.

Foresight Partners with One of the World’s Largest Industrial Equipment Manufacturers for POC Project

Retrieved on: 
Friday, August 11, 2023
Perception, 3D, Lidar, Mining, TASE, Weather, Foresight, POC, Environment, Safety, Medical imaging

Ness Ziona, Israel, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, announced today the signing of a paid proof of concept (POC) project with the Chinese subsidiary of one of the world’s leading manufacturers of industrial equipment, heavy machinery, construction and mining equipment.

Key Points: 
  • A successful POC project may lead to the integration of Foresight's technology into the industrial equipment manufacturer’s construction and mining trucks.
  • The industrial equipment manufacturer will evaluate Foresight’s technology to add 360° 3D perception capabilities to its mining and construction trucks, offering an alternative to its existing LiDAR sensors.
  • By collaborating with one of the world's largest industrial equipment and heavy machinery manufacturers, we aim to enhance the safety, accuracy of object detection, and environmental awareness in their operations.
  • This POC project reflects our dedication to delivering advanced automotive vision technologies across diverse sectors," said Haim Siboni, CEO of Foresight.